C2GnT1 gene knock-down results in decreased binding of cells to E-selectin. by Catherine A. St. Hill (357388)

“…At a shear stress of 0.5 dynes/cm², significantly fewer C2GnT1 shRNA transduced cells accumulated on E-selectin than un-manipulated LS174T cells, *p = 0.04. …”

miR-181b overexpression decreases cell mitochondrial membrane potential. by Samira Ghorbani (3843895)

Revisiting the sealed heating method–V158411 decreases Chk1 nuclear immunofluorescence in HT29 cells heated in a low well volume. by Andrew J. Massey (239469)

The levels of soluble Rpb1 are decreased in <i>not5Δ</i>. by Zoltan Villanyi (650435)

PGC-1β KO mice show a specific decrease in Mfn2 expression in skeletal muscle. by Marc Liesa (35879)

miR-214 decreased the number of viable cells and induced apoptosis in HSA cell lines. by Kazuki Heishima (791938)

“…<p>(A) Cell viability was assessed by performing the MTT assay. miR-214-transfection decreased the number of viable cells in HSA cell lines and that of control EC. …”

(A) Maximum percent decrease in FEV for each patient from postdose/pre-challenge after treatment with placebo (DB-placebo) or levalbuterol (DB-levalbuterol) during the double-blind... by D.S. Pearlman (92703)

RNF5 depletion decreases cellular gene expression and lytic replication through increased EphA3 and EphA4 level in iSLK.219 cells. by Xiaojuan Li (351842)

Imatinib decreases <i>in vivo</i> proliferation of T-cells. by Ludovic Belle (293091)

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…Representative values of at least two independent experiments. <i>Columns,</i> mean; <i>bars</i>, s.d. E) eRMS RD cells were treated during 24 hours with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”

DCB-3503 did not decrease mRNA levels of cyclin D1, survivin, β-catenin, p53, and p21. by Ying Wang (11406)

Cytosolic mitochondrial DNA release upon MeV and MeV-ΔV infection in culture and in mice. by Pierre Khalfi (7868252)

Subjects:

ASO treatment suppresses the palbociclib-mediated induction of MEG3 and decrease in cell proliferation in A549 cells. by Traci L. Kruer (3342425)

Apoptosis induction, ROS production and the decrease in MMP by DX1 treatment in HL-60 cells. by Zhiying Yu (356965)

Ex vivo exposure with different genotypes of HCV strains induced genotype-specific decrease of NKG2D expression on CD56+CD3+ lymphocytes. by Po-sung Chu (549427)

Subjects:

Decrease in <i>Sox2</i> expression results in similar phenotypes as disruptions to FGFR1 signaling. by Lu M. Yang (6919364)

Decreased PGC-1α expression is associated with a hyperglycemia-induced increase in mitochondrial fragmentation and ROS generation. by Kaifeng Guo (296791)

Decreased consumption of methionine sulfoxide (MetO) by the <i>V</i>. <i>cholerae</i> Δ<i>gcvT</i> mutant attenuates virulence by promoting intestinal lipid mobilization and insuli... by Audrey S. Vanhove (4090594)

Inhibition of ATR activation significantly decreases B19V-induced G2 arrest in infected CD36⁺ EPCs. by Peng Xu (17962)

POS treatment decreases ROS level and upregulates mitochondrial biogenesis in ARPE-19 cells through PGC-1α. by Murilo F. Roggia (755997)

“…<b>(D)</b> POS treatment decreased ROS level in cells transfected with control siRNA, but rather increased in those transfected with PGC-1α siRNA. …”